Targeting Protease-Activated Receptor-1 with Cell-Penetrating Pepducins in Lung Cancer-Reference-Cited by-同舟云学术

Targeting Protease-Activated Receptor-1 with Cell-Penetrating Pepducins in Lung Cancer

Published:2011-07 Issue:1 Volume:179 Page:513-523
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Cisowski Jaroslaw,O'Callaghan Katie,Kuliopulos Athan,Yang John,Nguyen Nga,Deng Qing,Yang Eric,Fogel Michael,Tressel Sarah,Foley Caitlin,Agarwal Anika,Hunt Stephen W.,McMurry Tom,Brinckerhoff Larry,Covic Lidija

Funder

NIH

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference53 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

2. Targeted therapies for non-small cell lung cancer;Dempke;Lung Cancer,2010

3. Beyond doublet chemotherapy for advanced non-small-cell lung cancer: combination of targeted agents with first-line chemotherapy;Herbst;Clin Lung Cancer,2009

4. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells;Boire;Cell,2005

5. Tumor-derived Cyr61 (CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells;Nguyen;Cancer Res,2006

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracellular Matrix Cues Regulate Mechanosensing and Mechanotransduction of Cancer Cells;Cells;2024-01-02

2. Beyond matrix stiffness: targeting force-induced cancer drug resistance;Trends in Cancer;2023-11

3. Effect of chimeric antigen receptor T cells against protease-activated receptor 1 for treating pancreatic cancer;BMC Medicine;2023-09-04

4. Suppression of Heart Failure With PAR1 Pepducin Technology in a Pressure Overload Model in Mice;Circulation: Heart Failure;2023-07-21

5. Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer;Biomarker Research;2023-06-06